Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-12-03Clinical Trial Update: Improving MEDication Adherence in Chronic Heart Failure Using a TELEmedicine Device (TELEMED-HF) [NA]
The TELEMED-HF trial evaluating a telemedicine device to improve medication adherence in chronic heart failure has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-11-17Clinical Trial Update: Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients
A pilot trial evaluating cardiovascular events in high-risk orthopedic surgical patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-11-11Clinical Trial Update: Double Blind Randomized Placebo Controlled Trial of Natrecor in Acute Decompensated Heart Failure With Normal EF [Phase 4]
A Phase 4, double-blind, randomized, placebo-controlled trial of nesiritide (Natrecor) in acute decompensated heart failure with normal ejec…
-
CLINICAL_TRIALS withdrawal · 2015-10-15Clinical Trial Update: A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Bendavia™ (MTP-131) in Patients With Heart Failure [Phase 1]
A Phase 1 multiple ascending dose trial of Bendavia (MTP-131) in heart failure has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-10-14Clinical Trial Update: Trial to Determine Imaging Parameters of LMI1195 in Heart Failure Patients at Low and High Risk of Defibrillator Firing [Phase 2]
A Phase 2 trial evaluating imaging parameters of LMI1195 in heart failure patients at low and high risk of defibrillator firing has been wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-09-24Clinical Trial Update: Calcium, Phosphate, Renal Impairment and Coronary Artery Disease in the Cardio-renal Syndrome, The CAPRICORN-CRS Study
The CAPRICORN-CRS trial investigating calcium, phosphate, renal impairment and coronary artery disease in cardio-renal syndrome for heart fa…
-
CLINICAL_TRIALS withdrawal · 2015-09-04Clinical Trial Update: Comparative Study to Examine Whether Echocardiography Performed During Cardiac Resynchronization Therapy Device Implantation Can Improve the Response Rate [NA]
This document reports the withdrawal of a trial comparing whether echocardiography performed during cardiac resynchronization therapy implan…
-
CLINICAL_TRIALS withdrawal · 2015-08-13Clinical Trial Update: Evaluation of Lung Doppler Signals in Patients Presenting to EMD
A clinical trial evaluating lung Doppler signals in patients presenting with acute cardiovascular conditions and pneumonia has been withdraw…
-
CLINICAL_TRIALS withdrawal · 2015-06-29Clinical Trial Update: OPTIMA Bi-ventricular Capture Verification Study
The OPTIMA Bi-ventricular Capture Verification Study (NCT00887055) sponsored by Guidant Corporation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-24Clinical Trial Update: A Comparison of the Effect of Carvedilol and Metoprolol on Airways Tone in Patients With Heart Failure [Phase 4]
A Phase 4 trial comparing carvedilol and metoprolol on airway tone in patients with heart failure and chronic obstructive pulmonary disease …
-
CLINICAL_TRIALS withdrawal · 2015-04-28Clinical Trial Update: Heart Failure Evaluation Acute Referral Team Trial (HEARTT) [NA]
The HEARTT trial evaluating heart failure evaluation by an acute referral team has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-04-13Clinical Trial Update: Hispanics With Metabolic Syndrome and Non-ischemic Heart Failure
The clinical trial NCT00804882 investigating Hispanics with metabolic syndrome and non-ischemic heart failure has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-31Clinical Trial Update: Cell Repair in Heart Failure [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial of cell repair therapy for heart failure and ischemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-02-06Clinical Trial Update: Cardiac Compass With Optivol® to Negate Future Inpatient Re-admissions Through Monitoring in HF Patients (CONFIRM-HF)
A clinical trial evaluating Cardiac Compass with Optivol to prevent inpatient readmissions in heart failure patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-02-03Clinical Trial Update: Endocardial Pacing in On-table Non-responders in Cardiac Resynchronization Therapy [NA]
A clinical trial evaluating endocardial pacing for on-table non-responders in cardiac resynchronization therapy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-12-02Clinical Trial Update: Telehealth Self Management for CHF [Phase 1, Phase 2]
The clinical trial investigating telehealth self-management for heart failure (NCT01812512) has been withdrawn from participation. It covere…
-
CLINICAL_TRIALS withdrawal · 2014-10-23Clinical Trial Update: Phase I Interaction Study of Istaroxime and Digoxin in Subjects With Stable Heart Failure [Phase 1]
Phase I study examining interaction between istaroxime and digoxin in subjects with stable heart failure has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-09-17Clinical Trial Update: Heart Failure and Regional Specific Exercise Training Stimulus [NA]
The clinical trial NCT02077426 evaluating region-specific exercise training for heart failure has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-09-09Clinical Trial Update: Study to Determine the Safety and Feasibility of Utilizing the CD Leycom Pressure/Conductance Catheter to Determine Optimal LV Pacing Site [Phase 1]
A Phase 1 study to assess the safety and feasibility of using the CD Leycom Pressure/Conductance Catheter to determine the optimal left vent…
-
EMA withdrawal · 2014-09-01EMA Refused: Reasanz (serelaxin) — Novartis Europharm Ltd
The EMA refused marketing authorization for Reasanz (serelaxin) by Novartis Europharm Ltd for heart failure.
-
CLINICAL_TRIALS withdrawal · 2014-07-17Clinical Trial Update: Evaluation of Remote Patient Monitoring.
A clinical trial evaluating remote patient monitoring for congestive heart failure and chronic obstructive pulmonary disease was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-06-26Clinical Trial Update: BMAC Enhanced Coronary Artery Bypass Grafting (CABG) [Phase 1, Phase 2]
A phase 1/2 trial evaluating bone marrow aspirate concentrate (BMAC) enhanced CABG for congestive heart failure was terminated.
-
CLINICAL_TRIALS withdrawal · 2014-06-26Clinical Trial Update: Evaluation of Blood Flow Patterns in Lung Blood Vessels Using Ultrasound Technique in Patients With Congestive Heart Failure
This clinical trial evaluating ultrasound assessment of lung blood flow in patients with congestive heart failure has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-06-17Clinical Trial Update: Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction [Phase 1]
A Phase 1 trial evaluating chimeric natriuretic peptide versus placebo in patients with stable heart failure and moderate renal dysfunction …
-
CLINICAL_TRIALS withdrawal · 2014-06-05Clinical Trial Update: Effects of Nesiritide in Pediatric Patients With Heart Failure [NA]
The pediatric trial evaluating Nesiritide for heart failure (NCT00166010) has been withdrawn.